Kura Oncology (KURA) Tops Q3 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q3 EPS of ($0.50), $0.04 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
• JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight